Lv6
2610 积分 2024-01-31 加入
Achievement of Guideline-Recommended Targets in Diabetes Care in China
12小时前
已完结
Vemurafenib for BRAF V600–Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis
1天前
已完结
Efbemalenograstim Alfa: First Approval
11天前
已完结
Efbemalenograstim Alfa-vuxw
11天前
已完结
Ryzneuta for Prevention of Febrile Neutropenia
11天前
已关闭
The impact of new and emerging agents on outcomes for febrile neutropenia: addressing clinical gaps
11天前
已完结
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Efbemalenograstim Alfa (F-627), a Novel Long-Acting rhG-CSF, in Healthy Chinese Participants: An Open-Label, Single-Center Phase I Study
11天前
已完结
Gamma-interferon induced human keratinocyte HLA-DR synthesis: the role of dermal activated T lymphocytes
21天前
已完结
Current State of Targeted Therapy in Adult Langerhans Cell Histiocytosis and Erdheim–Chester Disease
2个月前
已完结
皖公网安备34019202002308
